Sarcoidosis and tuberculosis: Epidemiological similarities and dissimilarities: A review of a series of studies in a Japanese work population (1941-1996) and the general population (1959-1984)

Sarcoidosis Vasculitis and Diffuse Lung Diseases

Volumn 21, Issue 2, 2004, Pages 85-93

  Hosoda, Yutaka ^a   Sasagawa, Sumiko ^b,d   Yamaguchi, Tetsuo ^c  

^a Maruishi Daini Bldg 5F   (Japan)

^b INSTITUTE FOR ENVIRONMENTAL SCIENCES   (Japan)

^c JR Tokyo General Hospital   (Japan)

^d NONE

Author keywords

Japanese work and general populations; Sarcoidosis; Tuberculosis

Indexed keywords

ADOLESCENT; ADULT; AGE; COHORT ANALYSIS; HUMAN; JAPAN; LUNG HILUS; LUNG TUBERCULOSIS; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL DISEASE; PRIORITY JOURNAL; REVIEW; SARCOIDOSIS; THORAX RADIOGRAPHY; TUBERCULIN TEST;

HEALTH SURVEYS; HUMANS; INCIDENCE; JAPAN; LYMPHATIC DISEASES; POPULATION SURVEILLANCE; PREVALENCE; SARCOIDOSIS, PULMONARY; TUBERCULIN TEST; TUBERCULOSIS, PULMONARY; WORK;

EID: 3242701438     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (73)

1. Mankiewicz E, van Walbeek M: Mycobacteriophages. Their role in tuberculosis and sarcoidosis. Arch Environ Health 1962; 5: 122-8.
2. rd Internat. Conf. on Sarcoidosis, Acta Med Scand 1964; 425S: 61-7.
3. Vaneck J, Schwarz J: Demonstration of acid-fast rods in sarcoidosis. Am Rev Respir Dis 1970; 101: 395-400.
4. th International Conference on Sarcoidosis, Prague, 1971. Prague: Universita Karlova 1971: 83-4.
5. th International Conference on Sarcoidosis, Prague 1971, Universita Karlova 1971: 89-92.
6. Nuscovic EA: Sarcoidosis and mycobacterial L forms. Pathol Anal 1987; 13: 69-164.
7. th World WASOG Congress, Milan. Amsterdam: Excerpta Medica, Elsevier, 1988: 161-4.
8. Thakker B, Black M, Foulis AK: Mycobacterial nucleic acids in sarcoid lesions. Lancet 1992; 339: 1537.
9. Saboor SA, Johnson NM, McFadden J: Detection of mycobacterial DNA in sarcoidosis and tuberculosis with polymerase chain reaction. Lancet 1992; 339: 1012-5.
10. Mitchell IC, Turk JL, Mitchell DN: Detection of mycobacterial rRNA in sarcoidosis with liquid-phase hibridisation. Lancet 1992; 339: 1015-7.
11. Milman N, Andersen AB: Detection of antibodies in serum against M tuberculosis using Western Blot technique. Comparison between sarcoidosis patients and healthy subjects. Sarcoidosis 1993; 10: 29-31.
12. Reid JD, Rodrick JC: Serological reactivity against Mycobacterium paratuberculosis antigens in patients with sarcoidosis. Sarcoidosis 1993; 10: 32-5.
13. Fidler HM, Rook GA, Johnson NM: Mycobacterium tuberculosis DNA in tissue affected by sarcoidosis. Br Med J 1993; 306: 546-9.
14. Almenoff PL, Johnson A, Lesser M, Mattman LH: Growth of acid fast L forms from the blood of patients with sarcoidosis. Thorax 1996; 51: 530-3.
15. el-Zaatari FA, Naser SA, Markeich DC, et al: Identification of Mycobacterium avium complex in sarcoidosis. J Clin Microbiol 1996; 34: 2240-5.
16. Mitchel DN: Mycobacteria and sarcoidosis. Lancet 1996; 348: 768-9.
17. Vokurka M, Lecossier D, du Bois RM, et al: Absence of DNA from mycobacteria of the M tuberculosis complex in sarcoidosis. Am J Respir Crit Care Med 1997; 156: 1000-3.
18. Popper HH, Klemen H, Hoefler G, Winter E: Presence of mycobacterial DNA in sarcoidosis. Hum Pathol 1997; 28: 796-800.
19. Ishige I, Usui Y, Takemura T, Eishi Y: Quantitative PCR of mycobacterial and propionibacterial DNA in lymph nodes of Japanese patients with sarcoidosis. Lancet 1999; 354: 120-3.
20. McGrath DS, Goh N, Foley PJ, du Bois RM: Sarcoidosis: genes and microbes: soil or seed? Sarcoidosis Vasc Diffuse Lung Dis 2001; 18: 149-64.
21. Martinetti M, Luisetti M, Cuccia M: HLA and sarcoidosis: new pathogenetic insights. Sarcoidosis Vasc Diffuse Lung Dis 2002; 19: 83-95.
22. Richter E, Greinert U, Kristen D, et al: Assessment of mycobacterial DNA in cells and tissues of mycobacterial and sarcoid lesions. Am J Respir Crit Care Med 1996, 153: 375-80.
23. Hill AB: The environment and disease: association or causation? Proc Roy Soc Med 1965; 58: 295-300.
24. Chiba Y, Shozawa M: Clinical study of tuberculous primary infection in: Development of Tuberculosis. Hokendojin-sha Tokyo 1948.
25. Chiba Y: Development of tuberculosis. 17 years since primary infection and chemoprophylaxis. Tokyo Hokendojinsha 1959.
26. Chiba Y, Hosoda Y, Aruga H: Frequency of detection of pulmonary sarcoidosis 1952-1959. Report No 7 Tokyo Health Institute 1961; 270-4.
27. th Int'l Conf. Sarcoidosis, University of Tokyo Press 1973: 303-6.
28. Hosoda E: Epidemiology of Sarcoidosis state-of-the-art: In: Grassi C, Rizzato G, Pozzi E (eds): Sarcoidosis. Amsterdam: Excerpta Medica. International Congress Series 1988; 756: 279-90.
29. Mori T: Tuberculin test. JATA Books. Japan Anti-Tuberculosis Association, 2000 (in Japanese).
30. Chiba Y, Takahara T, Nagashima A, et al: Antituberculous medication for tuberculin positive converters to prevent tuberculosis manifestation. (1) Results of PAS medication. Kekkaku 1954; 29S: 280-1.
31. Omodei Zorini A: Il momento attuale della tisiologia e l'attività dell'lstituto Carlo Forlanini durante il 1955. Lotta contro la TBC 1956; 8: 26.
32. Nobechi K, Yanagisawa K, Someya S, et al: Kousei kagaku: Studies on the method of evaluation of tuberculin test Report II, 1941; 2: 44-61 (in Japanese with English abstract).
33. Ranke KE: Primaraffekt, sekondarie und tertiare Stadien der Lungentuberculose. Deutch Arch Klin Medizin 1916; 119: 201-69.
34. Israel H: Acceptability of clinical diagnosis. Report of the medical group. Am Rev Respir Dis 1961; 84: 171-3.
35. Lofgren S: Primary pulmonary sarcoidosis. Early signs and symptoms. Acta Med Scand 1953; CXLV fasc. VI: 424-31.
36. Assmann H: Uber eine typische Form isolierter tuberculoser Lungenherde in klinischen Beginn der Erkrankung. Beitrage. Klin Tbc 1925; 60: 527-39.
37. Cummins SL: Primitive tribes and tuberculosis. Trans Society Trop Med Hygiene 1911-1912; 5: 245-55.
38. Von Rcdeker F: Epidemiologie und Statistik der Tuberkulose. In: Hein J, Kleinschmidt H, Uhelinger E (eds): Handbuch der Tuberkulose. Stuttgart: Georg Thieme Veerlag 1958: 407-98.
39. Iwasaki T: Tuberculosis in Japan. History of epidemic of tuberculosis and changes in counter-measaures. Japan Anti-Tuberculosis Association 1988 (in Japanese).
40. Hosoda Y, Saito N: Sarcoidosis. Lung and Heart 1983; 30: 32-42 (in Japanese with English abstract).
41. Hiraga Y, Uchiyama H, Hosoda Y: Annual sarcoidosis incidence (1986-1994) from case registry in a male work population. Sarcoidosis Vase Diffuse Lung Dis 1999; 16 (suppl. 1): 5.
42. Jindal SK, Gupta S: Sarcoidosis in India: a review of 125 biopsy-proven cases from eastern India. Sarcoidosis 1990; 7: 43-9.
43. Jindal SK, Gupta D, Aggarwal AN: Sarcoidosis in developing countries. Curr Opin Pulm Med 2000; 6: 448-54.
44. Jindal SK, Gupta D, Aggarwal AN: Sarcoidosis in India: practical issues and difficulties in diagnosis and management. Sarcoidosis Vasc Diffuse Lung Dis 2002; 19: 176-84.
45. Yigla M, Badarna-Abu-Ria N, Tov N, Ravell-Weiller D, Rubin AH: Sarcoidosis in northern Israel; clinical characteristics of 120 patients. Sarcoidosis Vasc Diffuse Lung Dis 2002; 19: 220-6.
46. Morb Mortality Weekly Report: Sarcoidosis among US Navy enlisted men, 1965-1993. MMWR 1997; 46: 539-43.
47. Byg K-E, Milman N, Hansen S: Sarcoidosis in Denmark 1980-1994. A registry-based incidence study comprising 5536 patients. Sarcoidosis Vasc Diffuse Lung Dis 2003; 20: 46-52.
48. Hosoda Y, Sasagawa S, Yasuda N, Yamaguchi T: Epidemiology of sarcoidosis, general approach. In: Baughman RP (ed): Sarcoidosis. New York: Marcel Dekker Inc 2004 (in press).
49. th International Conference of Sarcoidosis. University of Tokyo Press, 1974, 303-6.
50. Brett G: Epidemiological trends in tuberculosis and sarcoidosis in the district of London between 1958 and 1963. Tubercle 1965; 46: 413-6.
51. Hosoda Y, Tanaka M, Okui S: Bilateral hilar lymph node enlargement and pulmonary sarcoidosis in children. A 20 year observation on children hospitalized in Prinzregent Luitpold Kinderklinik. Report 7 of JNR Central Institute of Health 1961; 264-9 (in Japanese).
52. Hosoda Y, Hiraga Y, Odaka M, et al: A cooperative study of sarcoidosis in Asia and Africa: analytic epidemiology. Ann N Y Acad Sci 1976; 278: 355-65.
53. Hosoda Y, Osada H, Hiraga Y, Odaka M, Hashimoto T: Factors relating to prognosis in sarcoidosis. Lung and Heart 1971; 18: 46-55 (in Japanese).
54. Pirquet CV: Das Verhalten der kutanen Tuberkulin-reaktion wahrend der Masern. Deutsch Med Wschft 1908; 30: 1297-1300.
55. Schaumann J: Observations cliniques, bacteriologiques et serologiques, pour servir a l'etiologie de la lymphogranulomatose benigne. Bull Soc Franc Derm Syph 1934; 41: 1296-1327.
56. Nobechi K: Epidemiology of sarcoidosis in Japan. Preliminary report. Am J Respir Dis 1961; 84, Part II: 155-61.
57. th International Conference on Sarcoidosis, Universita Karlova Praha 1971: 156-9.
58. Sutherland I, Mitchell DN, D'Arcy Hart P: Incidence of intrathoracic sarcoidosis among young adults participating in a trial of tuberculosis vaccines. Br Med J 1965; 2: 497-503.
59. Fog AF, Wilbek E: Sarkoidosens epidemiologie in Denmark. Ugeskr Laeg 1974; 136: 2183-91.
60. Hosoda Y, Oka H, Chiba Y, Kitamura K: Long term observations on tuberculin sensitivity in sarcoidosis. In: La Sarcoidose. Paris: Masson et Cie 1967: 308-12.
61. Niitu Y: Intrathoracic sarcoidosis found among school children in Sendai in mass x-ray surveys of the chest. In: La Sarcoidose. Paris: Masson et Cie 1967: 392-9.
62. Kitamura K, Nobechi K, Oka H, Shigematsu I, Hosoda Y: Sarcoidosis in Japan. Observations on 700 cases. Am Rev Respir Dis 1967; 95: 953-6.
63. Yaguchi M, Hosoda Y, Sasaki R, Aoki K: Epidemiological study on sarcoidosis in Japan. Recent trends in incidence and prevalence rates and changes in epidemiological features. Sarcoidosis 1989; 6: 138-46.
64. Hosoda Y: Epidemiology. Mt Sinai J Med 1977; 44: 733-9.
65. th WASOG Congress, Kumamoto 1999.
66. Japan Anti-tuberculosis Association. Statistics of T.B. 1994, ed. Ministry of Health and Welfare 1994.
67. Hillerdal G, Nou E, Osterman K, Schmekel B: Sarcoidosis: Epidemiology and prognosis. A 15-year European study. Am Rev Respir Dis 1984; 130: 29-32.
68. A report of the Research Committee of the British Thoracic and Tuberculosis Association. Geographical variations in the incidence of sarcoidosisis in Great Britain: A comparative study of four areas. Tubercle 1969; 50: 211-32.
69. Henke CE, Henke G, Elveback LR, Beard CM, Ballard DJ, Kurland LT: The epidemiology of sarcoidosis in Rochester, Minnesota: A population-based study of incidence and survival. Am J Epidemiol 1986; 123: 840-5.
70. Japan Ministry of Health and Welfare. Statistics of tuberculosis in Japan in 1980. Japan Anti-tuberculosis Association 1980.
71. Tuberculosis Control Division, BSS Center for Disease Control, Atlanta, Georgia, 1974.
72. Hosoda Y, Yamaguchi M, Hiraga Y: Global epidemiology of sarcoidosis. What story do prevalence and incidence tell us? Clin Chest Med 1997; 18: 681-94.
73. Hosoda Y, Sasagawa S, Yasuda N: Epidemiology of sarcoidosis: new frontiers to explore. Curr Opin Pulm Med 2002; 8: 424-8.